Gadoversetamide

钆弗塞胺

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameGadoversetamide
Drug Alias NamegadoversetamidagadoversetamidegadoversetamidumOptimarkMP-1177 +[6] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsCentral Nervous System DiseasesLiver Diseases
Global Approved IndicationsContrast agentsCentral Nervous System DiseasesLiver Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMallinckrodt Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiebel-Flarsheim Company Llc
Active IndicationsN/A
Inactive IndicationsContrast agentsCentral Nervous System DiseasesLiver Diseases

Other Information

ATC CodeV08CA06
Related LinksWikipediaDrugBankKEGG